RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Microport Cardioflow Medtech Stock

Microport Cardioflow Medtech Revenue 2024

Microport Cardioflow Medtech Revenue

460.04 M CNY

Ticker

2160.HK

ISIN

KYG6082P1054

WKN

A2QML9

In 2024, Microport Cardioflow Medtech's sales reached 460.04 M CNY, a 36.83% difference from the 336.22 M CNY sales recorded in the previous year.

The Microport Cardioflow Medtech Revenue history

YEARREVENUE (undefined CNY)GROSS MARGIN (%)
2026e768.160,90
2025e582.41,19
2024e460.041,51
2023336.222,06
2022251.030,54
2021200.811,14
2020103.93-5,75
201921.5-92,10
2018--

Microport Cardioflow Medtech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Microport Cardioflow Medtech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Microport Cardioflow Medtech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Microport Cardioflow Medtech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Microport Cardioflow Medtech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Microport Cardioflow Medtech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Microport Cardioflow Medtech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Microport Cardioflow Medtech’s growth potential.

Microport Cardioflow Medtech Revenue, EBIT and net profit per share

DateMicroport Cardioflow Medtech RevenueMicroport Cardioflow Medtech EBITMicroport Cardioflow Medtech Net Income
2026e768.16 M undefined79.1 M undefined102.12 M undefined
2025e582.4 M undefined-98.94 M undefined-17.23 M undefined
2024e460.04 M undefined-208.93 M undefined-174.72 M undefined
2023336.22 M undefined-351.66 M undefined-471.53 M undefined
2022251.03 M undefined-330.23 M undefined-454.4 M undefined
2021200.81 M undefined-197.35 M undefined-183.26 M undefined
2020103.93 M undefined-138.87 M undefined-398.09 M undefined
201921.5 M undefined-124.51 M undefined-144.52 M undefined
20180 undefined-59.94 M undefined-60.26 M undefined

Microport Cardioflow Medtech stock margins

The Microport Cardioflow Medtech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Microport Cardioflow Medtech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Microport Cardioflow Medtech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Microport Cardioflow Medtech's sales revenue. A higher gross margin percentage indicates that the Microport Cardioflow Medtech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Microport Cardioflow Medtech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Microport Cardioflow Medtech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Microport Cardioflow Medtech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Microport Cardioflow Medtech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Microport Cardioflow Medtech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Microport Cardioflow Medtech Margin History

Microport Cardioflow Medtech Gross marginMicroport Cardioflow Medtech Profit marginMicroport Cardioflow Medtech EBIT marginMicroport Cardioflow Medtech Profit margin
2026e2.06 %10.3 %13.29 %
2025e2.06 %-16.99 %-2.96 %
2024e2.06 %-45.42 %-37.98 %
20232.06 %-104.59 %-140.25 %
20220.54 %-131.55 %-181.02 %
20211.14 %-98.27 %-91.26 %
2020-5.75 %-133.61 %-383.02 %
2019-92.1 %-579.05 %-672.13 %
20182.06 %0 %0 %

Microport Cardioflow Medtech Aktienanalyse

What does Microport Cardioflow Medtech do?

Microport Cardioflow Medtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Microport Cardioflow Medtech's Sales Figures

The sales figures of Microport Cardioflow Medtech originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Microport Cardioflow Medtech’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Microport Cardioflow Medtech's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Microport Cardioflow Medtech’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Microport Cardioflow Medtech stock

How much revenue did Microport Cardioflow Medtech generate this year?

Microport Cardioflow Medtech has achieved a revenue of 460.04 M CNY this year.

How much was the turnover of the company Microport Cardioflow Medtech compared to the previous year?

The revenue of Microport Cardioflow Medtech has increased by 36.83% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Microport Cardioflow Medtech?

The revenue of Microport Cardioflow Medtech is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Microport Cardioflow Medtech measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Microport Cardioflow Medtech so important for investors?

The revenue of Microport Cardioflow Medtech is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Microport Cardioflow Medtech pay?

Over the past 12 months, Microport Cardioflow Medtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Microport Cardioflow Medtech is expected to pay a dividend of 0 CNY.

What is the dividend yield of Microport Cardioflow Medtech?

The current dividend yield of Microport Cardioflow Medtech is .

When does Microport Cardioflow Medtech pay dividends?

Microport Cardioflow Medtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Microport Cardioflow Medtech?

Microport Cardioflow Medtech paid dividends every year for the past 0 years.

What is the dividend of Microport Cardioflow Medtech?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Microport Cardioflow Medtech located?

Microport Cardioflow Medtech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Microport Cardioflow Medtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Microport Cardioflow Medtech from 10/2/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Microport Cardioflow Medtech pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Microport Cardioflow Medtech in the year 2023?

In the year 2023, Microport Cardioflow Medtech distributed 0 CNY as dividends.

In which currency does Microport Cardioflow Medtech pay out the dividend?

The dividends of Microport Cardioflow Medtech are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Microport Cardioflow Medtech

Our stock analysis for Microport Cardioflow Medtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Microport Cardioflow Medtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.